Results 171 to 180 of about 242,018 (254)

Kutane Infektionen mit nicht‐tuberkulösen Mykobakterien: eine retrospektive Studie mit 94 Fällen aus Deutschland

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 5, Page 608-618, May 2026.
Zusammenfassung Hintergrund Kutane nichttuberkulöse Mykobakterien‐Infektionen (NTM) sind diagnostisch und therapeutisch herausfordernd. Ziel dieser Studie war die Charakterisierung kutaner NTM‐Infektionen in Deutschland über einen Zeitraum von 24 Jahren. Patienten und Methodik Eingeschlossen wurden 73 Patienten mit kutanen NTM‐Infektionen, die zwischen
Luisa Bopp, Nicolai Deresz, Henning Klapproth, Isabelle Suárez, Jonathan Jantsch, Mario Fabri, Esther von Stebut   +6 more
wiley   +1 more source

Efficacy of venetoclax-obinutuzumab treatment in achieving remission of acquired von Willebrand syndrome in chronic lymphocytic leukemia. [PDF]

Ann Hematol
Morelli F, Linari S, Rapolla CM, Attanasio M, Salvianti F, Sanna A.   +5 more
europepmc   +1 more source

Factors influencing front line treatment of chronic lymphocytic leukemia: A French real‐world study

Cancer, Volume 132, Issue 8, 15 April 2026.
Abstract Background Real‐world data are an essential complement to clinical trials. This is particularly true for chronic lymphocytic leukemia, where five first‐line options have never been directly compared. Methods The authors present the results of a national multicenter real‐world study focusing on treatment choices in frontline chronic lymphocytic
Arthur Coste, Nanthara Sritharan, Anne Lok, Cécile Tomowiak, Emmanuelle Ferrant, Aline Clavert, Damien Roos‐Weil, Florian Bouclet, Adrien Caillet, Carolyne Croizier, Nicolas Stocker, Emmanuelle Tchernonog, Pierre Feugier, Alberto Santagostino, Bénédicte Hivert, Anne‐Sophie Michallet, Sophie De Guibert, Diane Lara, Agathe Waultier‐Rascalou, Fatiha Merabet, Amandine Durand, Lucile Bussot, Kamel Laribi, Marie‐sarah Dilhuydy, Vincent Lévy, Anne Quinquenel   +25 more
wiley   +1 more source

Clonal haematopoiesis in chronic lymphocytic leukaemia: Biology, inflammaging and clinical implications in the era of targeted therapy. [PDF]

Clin Transl Med
Martino EA, Caserta S, Skafi M, Alvaro ME, Bruzzese A, Amodio N, Lucia E, Olivito V, Labanca C, Mendicino F, Vigna E, Morabito F, Gentile M.   +12 more
europepmc   +1 more source

Comparative Evaluation of Two Image-Analysis Software Platforms for Microfluidic Assessment of Red Blood Cell Deformability in Chronic Lymphocytic Leukemia. [PDF]

Micromachines (Basel)
Alexandrova-Watanabe A, Tiankov T, Iliev A, Langari A, Ivanova M, Gartcheva L, Guenova M, Abadjieva E, Krumova S, Todinova S.   +9 more
europepmc   +1 more source

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights. [PDF]

Leukemia
Parker H, Carr L, Norris K, Nilsson-Takeuchi A, Stevens B, Amarasinghe H, Kadalayil L, Else M, Clifford R, Pettitt A, Munir T, Schuh A, Walewska R, Baird DM, Oscier DG, Pepper C, Bryant D, Gibson J, Strefford JC.   +18 more
europepmc   +1 more source

Low serum IgE is associated with an increased risk of chronic lymphocytic leukemia: a large retrospective cohort study. [PDF]

Front Immunol
Cohen R, Elbirt D, Nemet S, Kirzhner A, Schiller T, Khadija HA, Bezalel-Rosenberg S, Asher I, Mahlab-Guri K, Wolach O, Hofstetter L.   +10 more
europepmc   +1 more source

Is CLL curable? [PDF]

Hemasphere
Jain N, Ferrajoli A, O'Brien S, Wierda W.   +3 more
europepmc   +1 more source

Nanobody-Engineered CLL-1 CAR T Cells: Optimizing Tumor-Specific Cytotoxicity and Minimizing Off-Tumor Toxicity. [PDF]

Cancer Res Commun
Tripathi C, Zolov S, Nguyen J, Luh F, Natarajan V, Yen Y.   +5 more
europepmc   +1 more source

CLL 189

Journal of Science, Humanities and Arts - JOSHA, 2017
Reinhard Marks, Nicolas Woitzik
openaire   +1 more source